225 related articles for article (PubMed ID: 37258672)
1. A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Momont C; Dang HV; Zatta F; Hauser K; Wang C; di Iulio J; Minola A; Czudnochowski N; De Marco A; Branch K; Donermeyer D; Vyas S; Chen A; Ferri E; Guarino B; Powell AE; Spreafico R; Yim SS; Balce DR; Bartha I; Meury M; Croll TI; Belnap DM; Schmid MA; Schaiff WT; Miller JL; Cameroni E; Telenti A; Virgin HW; Rosen LE; Purcell LA; Lanzavecchia A; Snell G; Corti D; Pizzuto MS
Nature; 2023 Jun; 618(7965):590-597. PubMed ID: 37258672
[TBL] [Abstract][Full Text] [Related]
2. Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective.
Madsen A; Dai YN; McMahon M; Schmitz AJ; Turner JS; Tan J; Lei T; Alsoussi WB; Strohmeier S; Amor M; Mohammed BM; Mudd PA; Simon V; Cox RJ; Fremont DH; Krammer F; Ellebedy AH
Immunity; 2020 Oct; 53(4):852-863.e7. PubMed ID: 32976769
[TBL] [Abstract][Full Text] [Related]
3. The antigenic landscape of human influenza N2 neuraminidases from 2009 until 2017.
Catani JPP; Smet A; Ysenbaert T; Vuylsteke M; Bottu G; Mathys J; Botzki A; Cortes-Garcia G; Strugnell T; Gomila R; Hamberger J; Catalan J; Ustyugova IV; Farrell T; Stegalkina S; Ray S; LaRue L; Saelens X; Vogel TU
Elife; 2024 May; 12():. PubMed ID: 38805550
[TBL] [Abstract][Full Text] [Related]
4. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells.
Piepenbrink MS; Nogales A; Basu M; Fucile CF; Liesveld JL; Keefer MC; Rosenberg AF; Martinez-Sobrido L; Kobie JJ
mBio; 2019 Mar; 10(2):. PubMed ID: 30862743
[TBL] [Abstract][Full Text] [Related]
5. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
[TBL] [Abstract][Full Text] [Related]
6. The neuraminidase of A(H3N2) influenza viruses circulating since 2016 is antigenically distinct from the A/Hong Kong/4801/2014 vaccine strain.
Wan H; Gao J; Yang H; Yang S; Harvey R; Chen YQ; Zheng NY; Chang J; Carney PJ; Li X; Plant E; Jiang L; Couzens L; Wang C; Strohmeier S; Wu WW; Shen RF; Krammer F; Cipollo JF; Wilson PC; Stevens J; Wan XF; Eichelberger MC; Ye Z
Nat Microbiol; 2019 Dec; 4(12):2216-2225. PubMed ID: 31406333
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
9. Isolation of human antibodies against influenza B neuraminidase and mechanisms of protection at the airway interface.
Wolters RM; Ferguson JA; Nuñez IA; Chen EE; Sornberger T; Myers L; Oeverdieck S; Raghavan SSR; Kona C; Handal LS; Esilu TE; Davidson E; Doranz BJ; Engdahl TB; Kose N; Williamson LE; Creech CB; Gibson-Corley KN; Ward AB; Crowe JE
Immunity; 2024 Jun; 57(6):1413-1427.e9. PubMed ID: 38823390
[TBL] [Abstract][Full Text] [Related]
10. Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.
Tan J; O'Dell G; Hernandez MM; Sordillo EM; Kahn Z; Kriti D; van Bakel H; Ellebedy AH; Wilson PC; Simon V; Krammer F; McMahon M
J Virol; 2022 Jan; 96(2):e0142121. PubMed ID: 34669506
[TBL] [Abstract][Full Text] [Related]
11. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
[No Abstract] [Full Text] [Related]
12. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.
Wilson JR; Guo Z; Reber A; Kamal RP; Music N; Gansebom S; Bai Y; Levine M; Carney P; Tzeng WP; Stevens J; York IA
Antiviral Res; 2016 Nov; 135():48-55. PubMed ID: 27713074
[TBL] [Abstract][Full Text] [Related]
13. Cross-neutralization of influenza A viruses mediated by a single antibody loop.
Ekiert DC; Kashyap AK; Steel J; Rubrum A; Bhabha G; Khayat R; Lee JH; Dillon MA; O'Neil RE; Faynboym AM; Horowitz M; Horowitz L; Ward AB; Palese P; Webby R; Lerner RA; Bhatt RR; Wilson IA
Nature; 2012 Sep; 489(7417):526-32. PubMed ID: 22982990
[TBL] [Abstract][Full Text] [Related]
14. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.
Doyle TM; Li C; Bucher DJ; Hashem AM; Van Domselaar G; Wang J; Farnsworth A; She YM; Cyr T; He R; Brown EG; Hurt AC; Li X
Biochem Biophys Res Commun; 2013 Nov; 441(1):226-9. PubMed ID: 24140051
[TBL] [Abstract][Full Text] [Related]
15. Broadly Reactive H2 Hemagglutinin Vaccines Elicit Cross-Reactive Antibodies in Ferrets Preimmune to Seasonal Influenza A Viruses.
Reneer ZB; Skarlupka AL; Jamieson PJ; Ross TM
mSphere; 2021 Mar; 6(2):. PubMed ID: 33692193
[TBL] [Abstract][Full Text] [Related]
16. Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.
Stadlbauer D; McMahon M; Turner HL; Zhu X; Wan H; Carreño JM; O'Dell G; Strohmeier S; Khalil Z; Luksza M; van Bakel H; Simon V; Ellebedy AH; Wilson IA; Ward AB; Krammer F
Nat Commun; 2022 Dec; 13(1):7864. PubMed ID: 36543789
[TBL] [Abstract][Full Text] [Related]
17. Broadly protective human antibodies that target the active site of influenza virus neuraminidase.
Stadlbauer D; Zhu X; McMahon M; Turner JS; Wohlbold TJ; Schmitz AJ; Strohmeier S; Yu W; Nachbagauer R; Mudd PA; Wilson IA; Ellebedy AH; Krammer F
Science; 2019 Oct; 366(6464):499-504. PubMed ID: 31649200
[TBL] [Abstract][Full Text] [Related]
18. A highly conserved neutralizing epitope on group 2 influenza A viruses.
Ekiert DC; Friesen RH; Bhabha G; Kwaks T; Jongeneelen M; Yu W; Ophorst C; Cox F; Korse HJ; Brandenburg B; Vogels R; Brakenhoff JP; Kompier R; Koldijk MH; Cornelissen LA; Poon LL; Peiris M; Koudstaal W; Wilson IA; Goudsmit J
Science; 2011 Aug; 333(6044):843-50. PubMed ID: 21737702
[TBL] [Abstract][Full Text] [Related]
19. Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
Rowe T; Davis W; Wentworth DE; Ross T
J Virol; 2024 Feb; 98(2):e0149423. PubMed ID: 38294251
[TBL] [Abstract][Full Text] [Related]
20. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
